Target intelligence / Profile preview

Mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase pseudogene

Molecular classification
Pseudogene, Non-coding RNA, Other
01

Overview

The "mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase pseudogene" (ENSG00000274601) is a pseudogene that shares sequence homology with the protein-coding gene MGAT2, which encodes an enzyme involved in N-glycan biosynthesis. Unlike MGAT2, the pseudogene does not encode a functional protein and is incapable of catalyzing glycosyltransferase reactions. Pseudogenes can play regulatory roles via noncoding RNA transcripts, potentially affecting their parent gene expression through mechanisms like competing endogenous RNA (ceRNA) networks or as sources of small interfering RNAs. However, such functions are context-dependent and not well characterized for each individual pseudogene[2][4][6][8]. In summary: ENSG00000274601 is a **pseudogene**—not a canonical therapeutic target (enzyme, receptor, etc.), and thus, it should not be considered a target for drug discovery or direct pharmacological modulation. It may have *regulatory RNA roles*, but these are not typically targeted in current drug development[2][4][6].

Other names
MGAT2 pseudogenemannosyl (alpha-1,6)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase pseudogene
02

Biological functions

Potential non-coding RNA regulatory functions (such as gene expression regulation via RNA interference, microRNA sponge activity, etc.), but no canonical protein function
03

Disease associations

Generally not directly associated with diseases, but some pseudogenes can have indirect roles in gene regulation, affecting processes like cancer via miRNA decoy functionsUsually categorized as "Other" or "Potential gene regulation"

Beyond the preview

Go deeper on Mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call